重性抑郁障碍的表观遗传衰老
该研究基于荷兰抑郁与焦虑研究,比较811例抑郁患者与319名无终生精神障碍且抑郁症状低的对照者的血液DNAm年龄,发现患者表观遗传衰老显著更高(Cohen's d=0.18),且随症状严重度呈剂量效应;该差异在74例抑郁患者与64名对照的死后脑组织中重复验证,并与童年创伤评分正相关。
要点
- 重性抑郁患者血液表观遗传衰老显著高于对照(Cohen's d=0.18)。
- 表观遗传衰老随症状严重度增加呈显著剂量效应。
- 脑组织重复验证该差异,童年创伤评分与表观遗传衰老正相关。
核心结论
- 重性抑郁患者血液与脑组织均显示更高的表观遗传衰老,提示其生物学年龄高于实际年龄。
- 童年创伤存在时该效应更为明显。
研究设计与样本
- 基于荷兰抑郁与焦虑研究,纳入811例抑郁患者与319名无终生精神障碍且抑郁症状低的对照者,用全甲基化位点估计血液DNAm年龄。
- 以DNAm年龄估计值对实际年龄回归的残差表示表观遗传衰老,分析校正社会人口学特征、生活方式与健康状况。
- 用74例抑郁患者与64名对照的死后脑样本进行重复验证,并用ConsensusPathDB进行通路富集分析。
主要发现
- 抑郁患者表观遗传衰老显著高于对照(Cohen's d=0.18)。
- 总体样本中表观遗传衰老随症状严重度增加呈显著剂量效应。
- 抑郁组内表观遗传衰老与童年创伤评分呈显著正相关。
- 病例对照差异在独立死后脑样本数据集中重复验证。
- 显著富集的Gene Ontology条目包括神经元相关过程。
关键数值与推荐
- 抑郁患者与对照的表观遗传衰老差异效应量Cohen's d=0.18。
- 表观遗传衰老与童年创伤评分在抑郁组内呈显著正相关。
临床怎么用
- 可将表观遗传衰老作为重性抑郁患者生物学老化评估的潜在研究性指标。
- 评估抑郁患者时应关注童年创伤史,其与更明显的表观遗传衰老相关。
- 症状严重度更高的患者可能表观遗传衰老更明显,提示需关注老化相关共病风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Major depressive disorder is associated with an increased risk of mortality and aging-related diseases. The authors examined whether major depression is associated with higher epigenetic aging in blood as measured by DNA methylation (DNAm) patterns, whether clinical characteristics of major depression have a further impact on these patterns, and whether the findings replicate in brain tissue. METHOD: DNAm age was estimated using all methylation sites in blood of 811 depressed patients and 319 control subjects with no lifetime psychiatric disorders and low depressive symptoms from the Netherlands Study of Depression and Anxiety. The residuals of the DNAm age estimates regressed on chronological age were calculated to indicate epigenetic aging. Major depression diagnosis and clinical characteristics were assessed with questionnaires and psychiatric interviews. Analyses were adjusted for sociodemographic characteristics, lifestyle, and health status. Postmortem brain samples of 74 depressed patients and 64 control subjects were used for replication. Pathway enrichment analysis was conducted using ConsensusPathDB to gain insight into the biological processes underlying epigenetic aging in blood and brain. RESULTS: Significantly higher epigenetic aging was observed in patients with major depression compared with control subjects (Cohen's d=0.18), with a significant dose effect with increasing symptom severity in the overall sample. In the depression group, epigenetic aging was positively and significantly associated with childhood trauma score. The case-control difference was replicated in an independent data set of postmortem brain samples. The top significantly enriched Gene Ontology terms included neuronal processes. CONCLUSIONS: As compared with control subjects, patients with major depression exhibited higher epigenetic aging in blood and brain tissue, suggesting that they are biologically older than their corresponding chronological age. This effect was even more profound in the presence of childhood trauma.
引用
- Han LKM, Aghajani M, Clark SL, et al. Epigenetic Aging in Major Depressive Disorder. Am J Psychiatry. 2018. PMID: 29656664. doi:10.1176/appi.ajp.2018.17060595
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。